Akebia Therapeutics Inc.

Akebia Therapeutics Inc.

AKBA

Market Cap$795.79M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Akebia Therapeutics Inc.Akebia Therapeutics Inc.-15.7--184%-2.3
$-2.20

Current Fair Value

159.7% downside

Overvalued by 159.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$795.79 Million
Enterprise Value$737.80 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.33
Beta0.88
Outstanding Shares235,497,720

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-15.75
PEG11.75
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue4.03
Enterprise Value to EBIT-31.21
Enterprise Value to Net Income-17
Total Debt to Enterprise0.08
Debt to Equity2.25

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Akebia Therapeutics Inc.

CEO: John Butler